发明名称 Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
摘要 One aspect of the present invention relates to methods of sealing a wound or tissue plane or filling a void space, or securing meshes, films or other devices within the body. In certain embodiments, the wound is an ophthalmic, pleural or dural wound, or a hernia repair mesh. Remarkably, disclosed herein is the discovery that the use of certain crosslinkers in combination with polyalkyleneimines at specific concentrations can result in hydrogels with tunable degradation properties.
申请公布号 US8846022(B2) 申请公布日期 2014.09.30
申请号 US201012909611 申请日期 2010.10.21
申请人 HyperBranch Medical Technology, Inc. 发明人 Carnahan Michael A.;Butlin Jared Daniel Goodnow
分类号 A61K31/785;A61K31/765;A61K6/08;C08G65/333;C08G65/326;C08G65/337;C08L71/02;A61L24/04;C08K5/3415;C08K5/00;C08L79/02;C08L77/04 主分类号 A61K31/785
代理机构 Foley Hoag LLP 代理人 Steele Alan W.;Foley Hoag LLP
主权项 1. A method of sealing a wound of a patient, comprising the steps of: combining effective amounts of an activated polyethylene glycol diacid derivative and a covalent crosslinking agent to form a polymeric composition; and applying said polymeric composition to a wound of a patient; wherein the covalent crosslinking agent is polyethyleneimine having a weight average molecular weight of about 400 to about 2000 Daltons; the molar ratio of activated esters on the polyethylene glycol diacid derivative to primary amines on the polyethyleneimine is within a range of about 0.5:1 to about 1.5:1; and the activated polyethylene glycol diacid derivative is represented by formula I: wherein, independently for each occurrence, R is H; m is 5 to 10 inclusive; and w is 20 to 120 inclusive.
地址 Durham NC US